REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Holandina Pharmaceutical de Colombia S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Holandina Pharmaceutical de Colombia S.A.S. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

The company Holandina Pharmaceutical De Colombia S.A.S. is primarily engaged in drugs and druggists' sundries merchant wholesalers and related activities. It's been operating in the Colombian market since 2003.

Headquarters
Cr 62 98 B 22 Of 201
Bogota D.C.; Bogota D.C; Postal Code: 0824

Contact Details: Purchase the Holandina Pharmaceutical de Colombia S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Holandina Pharmaceutical de Colombia S.A.S. report to view the information.
Outstanding Shares:
Purchase the Holandina Pharmaceutical de Colombia S.A.S. report to view the information.
Incorporation Date:
July 02, 2003
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
20%
Purchase this report to view the information.
10%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Holandina Pharmaceutical de Colombia S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
20.04%▲
Total operating revenue
20.04%▲
Operating profit (EBIT)
33.99%▲
Net Profit (Loss) for the Period
35.36%▲
Total assets
16.68%▲
Total equity
9.83%▲
Operating Profit Margin (ROS)
1.06%▲
Net Profit Margin
0.33%▲
Return on Equity (ROE)
1.69%▲
Quick Ratio
0.46%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo